Evidence map›Paper›PMID 33294695›Full record

ArticleHeliyon2020

Novel metric for managing the protection of humanity and the environment against pollution and its adverse effects.

William Ejuvweyerome Odiete

Abstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

William Ejuvweyerome OdieteDepartment of Civil Engineering, University of Nigeria, University Road, Nsukka, Enugu State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pollution prevention and control are very significant for protecting humanity and the environment against pollution and its adverse effects worldwide. The primary resistance of every country to the occurrence of any of the adverse effects of pollution is a function of the country's pollution prevention & control. Strengthening pollution prevention & control in a country is tantamount to preventing the occurrence of any of the adverse effects of pollution (including any of the pollution-related communicable diseases). Knowing the status of the pollution prevention & control in a country will enable its Government to plan and improve on it. This research work conducted a survey on the extent of availability of pollution prevention & control infrastructure, availability of environmental regulatory agencies and compliance of operating companies to environmental regulations in the Niger Delta. Based on the outcome of the survey, this work invented a novel composite metric titled "Pollution Prevention & Control Index" (PPCI) for measuring the status of pollution prevention & control in a country or region. It is a measure of the protection of the population and the environment against pollution and its adverse effects. Results revealed that the higher the pollution prevention & control index of a country, the smaller the work left undone (or the work to be done) to protect the environment and the population of the country against pollution, its adverse effects and vice versa. Results also showed that the generic pollution prevention & control index of a developed country is higher than that of a developing country.

Indexed as

Communicable diseasesEngineeringEnvironmental analysisEnvironmental assessmentEnvironmental engineeringEnvironmental hazardEnvironmental healthEnvironmental managementEnvironmental pollutionEnvironmental protectionEnvironmental regulationsEnvironmental risk assessmentEnvironmental sciencePollution preventionPollution prevention & control indexRegulatory agencies

Identifiers

PMID33294695
PMCPMC7689401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.